These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 38559586)

  • 1. Knockdown of INPP5K compromises the differentiation of N2A cells.
    Manzolillo A; Gresing L; Hübner CA; Franzka P
    Front Mol Neurosci; 2024; 17():1356343. PubMed ID: 38559586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutations in INPP5K Cause a Form of Congenital Muscular Dystrophy Overlapping Marinesco-Sjögren Syndrome and Dystroglycanopathy.
    Osborn DPS; Pond HL; Mazaheri N; Dejardin J; Munn CJ; Mushref K; Cauley ES; Moroni I; Pasanisi MB; Sellars EA; Hill RS; Partlow JN; Willaert RK; Bharj J; Malamiri RA; Galehdari H; Shariati G; Maroofian R; Mora M; Swan LE; Voit T; Conti FJ; Jamshidi Y; Manzini MC
    Am J Hum Genet; 2017 Mar; 100(3):537-545. PubMed ID: 28190459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The phosphoinositide 5-phosphatase INPP5K: From gene structure to in vivo functions.
    Schurmans S; Vande Catsyne CA; Desmet C; Moës B
    Adv Biol Regul; 2021 Jan; 79():100760. PubMed ID: 33060052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations in INPP5K, Encoding a Phosphoinositide 5-Phosphatase, Cause Congenital Muscular Dystrophy with Cataracts and Mild Cognitive Impairment.
    Wiessner M; Roos A; Munn CJ; Viswanathan R; Whyte T; Cox D; Schoser B; Sewry C; Roper H; Phadke R; Marini Bettolo C; Barresi R; Charlton R; Bönnemann CG; Abath Neto O; Reed UC; Zanoteli E; Araújo Martins Moreno C; Ertl-Wagner B; Stucka R; De Goede C; Borges da Silva T; Hathazi D; Dell'Aica M; Zahedi RP; Thiele S; Müller J; Kingston H; Müller S; Curtis E; Walter MC; Strom TM; Straub V; Bushby K; Muntoni F; Swan LE; Lochmüller H; Senderek J
    Am J Hum Genet; 2017 Mar; 100(3):523-536. PubMed ID: 28190456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Recurrent Pathogenic Variant of
    D'Amico A; Fattori F; Nicita F; Barresi S; Tasca G; Verardo M; Pizzi S; Moroni I; De Mitri F; Frongia A; Pane M; Mercuri E; Tartaglia M; Bertini E
    Front Genet; 2020; 11():565868. PubMed ID: 33193651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. INPP5K variant causes autosomal recessive congenital cataract in a Pakistani family.
    Yousaf S; Sheikh SA; Riazuddin S; Waryah AM; Ahmed ZM
    Clin Genet; 2018 Mar; 93(3):682-686. PubMed ID: 28940338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of INPP5K attenuates IP
    Loncke J; Luyten T; Ramos AR; Erneux C; Bultynck G
    BBA Adv; 2023; 4():100105. PubMed ID: 37842182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defective lysosome reformation during autophagy causes skeletal muscle disease.
    McGrath MJ; Eramo MJ; Gurung R; Sriratana A; Gehrig SM; Lynch GS; Lourdes SR; Koentgen F; Feeney SJ; Lazarou M; McLean CA; Mitchell CA
    J Clin Invest; 2021 Jan; 131(1):. PubMed ID: 33119550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bidirectional interconversion between PtdIns4P and PtdIns(4,5)P
    Eramo MJ; Gurung R; Mitchell CA; McGrath MJ
    Autophagy; 2021 May; 17(5):1287-1289. PubMed ID: 33879025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TRAPPC11-related muscular dystrophy with hypoglycosylation of alpha-dystroglycan in skeletal muscle and brain.
    Munot P; McCrea N; Torelli S; Manzur A; Sewry C; Chambers D; Feng L; Ala P; Zaharieva I; Ragge N; Roper H; Marton T; Cox P; Milev MP; Liang WC; Maruyama S; Nishino I; Sacher M; Phadke R; Muntoni F
    Neuropathol Appl Neurobiol; 2022 Feb; 48(2):e12771. PubMed ID: 34648194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Duplicated zebrafish (Danio rerio) inositol phosphatases inpp5ka and inpp5kb diverged in expression pattern and function.
    Shukla D; Gural BM; Cauley ES; Battula N; Mowla S; Karas BF; Roberts LE; Cavallo L; Turkalj L; Moody SA; Swan LE; Manzini MC
    Dev Genes Evol; 2023 Jun; 233(1):25-34. PubMed ID: 37184573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The inositol Inpp5k 5-phosphatase affects osmoregulation through the vasopressin-aquaporin 2 pathway in the collecting system.
    Pernot E; Terryn S; Cheong SC; Markadieu N; Janas S; Blockmans M; Jacoby M; Pouillon V; Gayral S; Rossier BC; Beauwens R; Erneux C; Devuyst O; Schurmans S
    Pflugers Arch; 2011 Dec; 462(6):871-83. PubMed ID: 21938401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of an independent tumor suppressor locus telomeric to Tp53 suggested Inpp5k and Myo1c as novel tumor suppressor gene candidates in this region.
    Hedberg Oldfors C; Dios DG; Linder A; Visuttijai K; Samuelson E; Karlsson S; Nilsson S; Behboudi A
    BMC Genet; 2015 Jul; 16():80. PubMed ID: 26170120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The inositol 5-phosphatase INPP5K participates in the fine control of ER organization.
    Dong R; Zhu T; Benedetti L; Gowrishankar S; Deng H; Cai Y; Wang X; Shen K; De Camilli P
    J Cell Biol; 2018 Oct; 217(10):3577-3592. PubMed ID: 30087126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphoinositide 5-phosphatases SKIP and SHIP2 in ruffles, the endoplasmic reticulum and the nucleus: An update.
    Ramos AR; Ghosh S; Suhel T; Chevalier C; Obeng EO; Fafilek B; Krejci P; Beck B; Erneux C
    Adv Biol Regul; 2020 Jan; 75():100660. PubMed ID: 31628071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutations in B3GALNT2 cause congenital muscular dystrophy and hypoglycosylation of α-dystroglycan.
    Stevens E; Carss KJ; Cirak S; Foley AR; Torelli S; Willer T; Tambunan DE; Yau S; Brodd L; Sewry CA; Feng L; Haliloglu G; Orhan D; Dobyns WB; Enns GM; Manning M; Krause A; Salih MA; Walsh CA; Hurles M; Campbell KP; Manzini MC; ; Stemple D; Lin YY; Muntoni F
    Am J Hum Genet; 2013 Mar; 92(3):354-65. PubMed ID: 23453667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. INPP5K and SIL1 associated pathologies with overlapping clinical phenotypes converge through dysregulation of PHGDH.
    Hathazi D; Cox D; D'Amico A; Tasca G; Charlton R; Carlier RY; Baumann J; Kollipara L; Zahedi RP; Feldmann I; Deleuze JF; Torella A; Cohn R; Robinson E; Ricci F; Jungbluth H; Fattori F; Boland A; O'Connor E; Horvath R; Barresi R; Lochmüller H; Urtizberea A; Jacquemont ML; Nelson I; Swan L; Bonne G; Roos A
    Brain; 2021 Sep; 144(8):2427-2442. PubMed ID: 33792664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inositol Polyphosphate-5-Phosphatase K (
    Kauer SD; Fink KL; Li EHF; Evans BP; Golan N; Cafferty WBJ
    J Neurosci; 2022 Mar; 42(11):2190-2204. PubMed ID: 35135857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TRAPPC11 and GOSR2 mutations associate with hypoglycosylation of α-dystroglycan and muscular dystrophy.
    Larson AA; Baker PR; Milev MP; Press CA; Sokol RJ; Cox MO; Lekostaj JK; Stence AA; Bossler AD; Mueller JM; Prematilake K; Tadjo TF; Williams CA; Sacher M; Moore SA
    Skelet Muscle; 2018 May; 8(1):17. PubMed ID: 29855340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. POGLUT1 biallelic mutations cause myopathy with reduced satellite cells, α-dystroglycan hypoglycosylation and a distinctive radiological pattern.
    Servián-Morilla E; Cabrera-Serrano M; Johnson K; Pandey A; Ito A; Rivas E; Chamova T; Muelas N; Mongini T; Nafissi S; Claeys KG; Grewal RP; Takeuchi M; Hao H; Bönnemann C; Lopes Abath Neto O; Medne L; Brandsema J; Töpf A; Taneva A; Vilchez JJ; Tournev I; Haltiwanger RS; Takeuchi H; Jafar-Nejad H; Straub V; Paradas C
    Acta Neuropathol; 2020 Mar; 139(3):565-582. PubMed ID: 31897643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.